TerminatedNot applicableNCT01859338

Soft Tissue Detection on MRI, Cone Beam CT and Fan Beam CT and Integration of Functional MRI

This clinical trial studies magnetic resonance imaging (MRI), cone beam computed tomography (CT), and fan beam CT in detecting soft tissue in patients with prostate and lung cancer undergoing radiation therapy. Comparing results of diagnostic procedures done before and during radiation therapy may help doctors predict a patient's response to treatment and help plan the best treatment.

Checked against the public recordLast updated Mar 7, 2018 · Source: ClinicalTrials.gov

StatusTerminated
PhaseNot applicable
U.S. locations1
SponsorVirginia Commonwealth University
01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Virginia Commonwealth University
Interventions being studied
Radiation: cone-beam computed tomography; Radiation: magnetic resonance imaging; Radiation: computed tomography
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
03
Public criteria

Who may be able to participate

Inclusion Criteria: * Patients with lung cancer visible on CT who are scheduled to receive radiation treatment to the area of the primary tumor will be eligible for this study - Renal function tests (blood urea nitrogen \[BUN\], creatinine \[Cr\], glomerular filtration rate \[GFR\]) within 30 days of MRI with GFR \> 59 mL/min * All patients must give written informed consent on a form that includes Health Insurance Portability and Accountability Act (HIPAA) authorization; patient therapy will not be directed by enrollment in this study; participation in this study will not preclude patient participation in additional therapy protocols; subjects will all be recruited from patients undergoing radiotherapy at one of the Virginia Commonwealth University (VCU)-affiliated radiotherapy clinics Exclusion Criteria: * Patients requiring continuous supplemental oxygen * Patients with metal implants including pace makers and defibrillators * Patients with cerebral aneurysm clips or middle ear implant * Patients with pain pump, a programmable shunt, or non-surgical metal (i.e. a foreign body) * Claustrophobic patients * Prior radiotherapy to body area under investigation * No vulnerable populations will be enrolled (prisoners, children, pregnant females, or institutionalized individuals); women of childbearing potential will undergo a pregnancy test

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Virginia Commonwealth University/Massey Cancer CenterRichmond, Virginia

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Mar 7, 2018. Always confirm current availability with the study team.

View original record ↗